Stay updated on MEDI4736 in Myelodysplastic Syndrome Clinical Trial

Sign up to get notified when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:25:41.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the number of participants enrolled in the Phase 1 study evaluating the safety and antitumor activity of MEDI4736 in subjects with Myelodysplastic Syndrome.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:53.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying that adult subjects with pathologically confirmed MDS who did not respond, relapsed, or could not tolerate hypomethylating agents are eligible. Previously, no specific information was provided about the participation criteria.
    Difference
    11%
    Check dated 2024-05-22T20:55:44.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:36:26.000Z thumbnail image

Stay in the know with updates to MEDI4736 in Myelodysplastic Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.